Bausch & Lomb (BLCO) Gains from Investment Securities (2021 - 2026)
Bausch & Lomb (BLCO) reported Gains from Investment Securities of $19.0 million for Q1 2026, up 1800.0% on a YoY basis from $1.0 million in Q1 2025, and down 17.39% quarter-over-quarter from $23.0 million in Q4 2025.
Bausch & Lomb (BLCO) Gains from Investment Securities (2021 - 2026) Analysis & Trends
Bausch & Lomb has reported Gains from Investment Securities for 6 years, with the latest figure at $19.0 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 1800.0% year-over-year to $19.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (up 102.7% YoY), and the FY2025 full-year result was -$27.0 million, down 200.0% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $19.0 million, down from $23.0 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $31.0 million in Q1 2023, with the low at -$39.0 million in Q4 2024.
- Historically, Gains from Investment Securities has averaged -$642857.1 across 5 years, with a median of $1.0 million in 2023.
- Annual changes were most pronounced in 2024 — Gains from Investment Securities sank 4000.0% — and 2026, when it surged 1800.0%.
- Bausch & Lomb's Gains from Investment Securities stood at $18.0 million in 2022, then sank by 94.44% to $1.0 million in 2023, then slumped by 4000.0% to -$39.0 million in 2024, then soared by 158.97% to $23.0 million in 2025, then decreased by 17.39% to $19.0 million in 2026.
- The last three Gains from Investment Securities figures came in at $19.0 million (Q1 2026), $23.0 million (Q4 2025), and -$23.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Bausch & Lomb | 5.32 Bn | 5.12 Bn | 973.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.00 Mn |
| Mar 31, 2026 | 19.00 Mn |
| Dec 31, 2025 | 23.00 Mn |
| Dec 31, 2025 | 23.00 Mn |
| Sep 30, 2025 | -23.00 Mn |
| Sep 30, 2025 | -23.00 Mn |
| Jun 30, 2025 | -18.00 Mn |
| Jun 30, 2025 | -18.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | -39.00 Mn |
| Dec 31, 2024 | -39.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | -4.00 Mn |
| Sep 30, 2023 | -4.00 Mn |